MTOR and Hepatic fibrosis: In a mouse model of liver fibrosis, TDF leads to aHSC apoptosis by downregulating the PI3K/Akt/mammalian target of rapamycin (mTOR) signaling pathway and ultimately improving liver fibrosis [96].